Caffeine Kinetics and CrossFit®-Specific Performance

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

July 29, 2024

Study Completion Date

July 30, 2024

Conditions
SupplementationSports NutritionErgogenic SupportDiscipline-specific Performance
Interventions
DIETARY_SUPPLEMENT

CAFMONO supplementation

"CAFMONO supplementation - random blind acute intake of in individual dose providing 3mg/kg BM of CAF.~CAFMONO - Caffeine (anhydrous caffeine), Ostrovit Sp. z o.o., Zambrów, POLAND"

DIETARY_SUPPLEMENT

CAFMIPS_1 supplementation

"CAFMIPS\_1 supplementation - random blind acute intake of in individual dose providing 3mg/kg BM of CAF.~CAFMIPS\_1 - Olimp Redweiler, Olimp Laboratories Sp. z o.o., Dębica, POLAND~CAFMIPS\_1 - Olimp Redweiler, Olimp Laboratories Sp. z o.o., Dębica, POLAND"

DIETARY_SUPPLEMENT

CAFMIPS_2 supplementation

"CAFMIPS\_2 supplementation - random blind acute intake of in individual dose providing 3mg/kg BM of CAF.~CAFMIPS\_2 - Muscle Clinic Furious, Noblepharma UG, BerlinVertrieb, GERMANY."

DIETARY_SUPPLEMENT

Placebo treatment

Placebo treatment - random blind acute intake of placebo preparation. Placebo will match the remaining test preparations with taste, colour and consistency, however it will be free of caffeine and any other substances possessing ergogenic potential.

Trial Locations (1)

61-871

RECRUITING

Department of Sports Dietetics, Poznan University of Physical Education, Poznan

All Listed Sponsors
collaborator

National Science Centre, Poland

OTHER_GOV

collaborator

Poznan University of Life Sciences

OTHER

lead

Poznan University of Physical Education

OTHER